Page last updated: 2024-09-05

tolvaptan and epidermal growth factor

tolvaptan has been researched along with epidermal growth factor in 1 studies

Compound Research Comparison

Studies (tolvaptan)	Trials (tolvaptan)	Recent Studies (post-2010) (tolvaptan)	Studies (epidermal growth factor)	Trials (epidermal growth factor)	Recent Studies (post-2010) (epidermal growth factor)
967	172	786	24,155	217	4,699

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boertien, WE; Engels, GE; Gansevoort, RT; Harskamp, LR; Meijer, E; van Goor, H; van Oeveren, W	1

Other Studies

1 other study(ies) available for tolvaptan and epidermal growth factor

Article	Year
Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan. Clinical journal of the American Society of Nephrology : CJASN, 2015, Oct-07, Volume: 10, Issue:10 Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Case-Control Studies; EGF Family of Proteins; Epidermal Growth Factor; Female; Glomerular Filtration Rate; Heparin-binding EGF-like Growth Factor; Humans; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Polycystic Kidney, Autosomal Dominant; Severity of Illness Index; Tolvaptan; Transforming Growth Factor alpha	2015

Article

Year

Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Clinical journal of the American Society of Nephrology : CJASN, 2015, Oct-07, Volume: 10, Issue:10

Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Case-Control Studies; EGF Family of Proteins; Epidermal Growth Factor; Female; Glomerular Filtration Rate; Heparin-binding EGF-like Growth Factor; Humans; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Polycystic Kidney, Autosomal Dominant; Severity of Illness Index; Tolvaptan; Transforming Growth Factor alpha

2015